针对化学疗法效应的3D基因组,通过人环素向3D基因组
bioRxiv : the preprint server for biology
|October 28, 2024
概括
人环素选择性地向3D基因组,通过破坏染色体循环的CTCF结合. 这种机制为异常3D染色体结构的癌症提供了新的治疗策略,包括急性髓性白血病.
科学领域:
- 基因组学就是基因组学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
背景情况:
- 细胞染色质折叠成调节基因转录的3D结构.
- 异常的3D染色体折叠与急性髓性白血病 (AML) 等疾病有关.
- 人环素拓胺酶II抑制剂会导致基因组驱逐和DNA损伤.
研究的目的:
- 为了绘制基因组范围的,高分辨率的化学疗法作用的Anthracyclines.
- 为了研究在3D染色体结构上抗环素作用的分子机制.
- 探索针对癌症3D基因组的治疗潜力.
主要方法:
- 全基因组的ATAC-seq以描述组织激素驱逐的情况.
- TOP2A ChIP-seq用于识别DNA损伤区域.
- Hi-C实验以评估3D染色体组织.
- 对AML患者数据的分析.
主要成果:
- 显而易见的 antracyclines 显示了对表观基因组区域的选择性向.
- 人环素通过干扰CTCF结合来破坏染色质循环.
- 用选择性环素治疗改变了K562细胞中的3D染色体组织.
- 接受 antracyclines 治疗的 AML 患者表现出与临床结果相关的染色质结构变化.
结论:
- 人环素是强效的,有选择性的表观基因组药物,针对3D基因组.
- 破坏3D染色体组织提供了一种新的抗癌治疗方法.
- 针对3D基因组使用Anthracyclines可能可以实现针对异常结构瘤的个性化药物.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K